Rockford woman is 1st in Wisconsin to receive newly-approved FDA ALS treatment

-
5:34
CBS 58’s Theater Thursdays: ’A Big Bold Beautiful Adventure’...
-
4:37
Rustic Road Brewing brings Oktoberfest celebration to Kenosha...
-
0:37
Man shot by officer after dropping and reaching for gun during...
-
2:58
Family and friends mourn crash victims as 2 remain hospitalized;...
-
1:10
CBS 58’s One Good Thing: Mike Curkov and Lance Allan talk with...
-
0:55
Ascension Elmbrook aims to combat isolation with social meal...
-
0:53
Fans hope Marquette-Wisconsin matchup helps boost women’s sports...
-
2:18
‘We can’t control the city’: Family and football coach...
-
2:14
Milwaukee mother mourns son, 11, fatally shot near 68th and...
-
2:08
Driver fleeing traffic stop crashes into car at 35th and Vliet,...
-
2:31
Milwaukee leaders call on parents, community after several violent...
-
2:01
Family of woman killed by MPD squad wants answers: ’How could...
ROCKFORD, Ill. (CBS 58) -- A Rockford, Illinois woman is the first in Wisconsin to receive a new FDA-approved treatment for ALS, or Lou Gehrig's disease.
Michelle Francis was first diagnosed in 2019 with what's called the SOD1 mutation.
The disease has run in her family for seven generations, affecting 65 members and counting.
In April, UW Health in Madison offered a glimmer of hope -- a monthly treatment involved removing spinal fluid with a needle and replacing it with a new drug.
Now, nearly eight appointments later, Francis says she has hope for the first time.
"It will be here forever so we definitely have to have something to once you develop, there's some hope and I’m thinking this is gonna be it," said Francis.
Francis says she hopes others with ALS will hear her story, be inspired, and most importantly, not give up.